ArticleArchives of osteoporosis2025
Integrated ortho-internal model reduces mortality in high-risk aged hip fractures.
Article in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This pioneering study validates a novel ortho-internal treatment model providing integrated fracture and comorbidity management for high-risk elderly hip fracture patients. Results confirm significantly reduced mortality versus conventional approaches, demonstrating its unique capacity to optimize both surgical and non-surgical therapies while establishing surgery as the preferred option for eligible patients under this model.
backgroundHip fractures in aged individuals with comorbidities pose complex treatment challenges and high mortality rates. While multiple multidisciplinary care models have been proposed globally, outcomes remain suboptimal for such cases. The present study assessed the efficacy of an ortho-internal treatment model, an integrated healthcare approach where physicians provide comprehensive care for patients with hip fractures and associated multiple comorbidities, to determine whether this novel model yields superior outcomes compared to existing multidisciplinary standards.
methodsWe retrospectively analyzed 1410 hip fracture patients treated at Tianjin Hospital's Ortho-internal Department (2015-2021), collecting demographic data, clinical information, and 1-year survival status. The main outcomes were mortality at 30, 60, 90, and 180 days and 1 year.
resultsOf 1410 patients (mean age 80.61 ± 8.28 years, 68.16% with Charlson Comorbidity Index ≥ 5), 353 underwent surgery and 1057 received non-surgical treatment. Overall mortality rates at 30, 60, 90, and 180 days and 1 year were 7.01%, 10.07%, 12.41%, 17.09%, and 21.56%, respectively. Surgical group mortality rates at these time points (3.40%, 5.10%, 6.23%, 9.35%, 12.18%) were significantly lower than the non-surgical group (8.23%, 11.73%, 14.47%, 19.68%, 24.69%). The overall 5-year survival rate exceeded 50%, with the surgery group (66.6%) significantly higher than the non-surgery group (46.7%) and the entire cohort.
conclusionThe ortho-internal model shows advantages in treating aged hip fracture patients with multiple comorbidities, outperforming published outcomes and offering a novel, effective approach to their care. Its capacity to optimize both surgical and conservative outcomes suggests this approach should be prioritized for complex cases. Notably, the model enables surgical access for previously ineligible patients, with surgery remaining beneficial despite higher perioperative risks.
Indexed as
Identifiers
41422444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.